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Abstract. 
 
CDO, a member of the Ig/fibronectin type 
III repeat subfamily of transmembrane proteins that in-
cludes the axon guidance receptor Robo, was identified 
by virtue of its down-regulation by the 
 
ras
 
 oncogene. 
We report here that one prominent site of 
 
cdo
 
 mRNA 
expression during murine embryogenesis is the early 
myogenic compartment (newly formed somites, der-
momyotome and myotome). CDO is expressed in pro-
liferating and differentiating C2C12 myoblasts and in 
myoblast lines derived by treating 10T1/2 fibroblasts 
with 5-azacytidine, but not in parental 10T1/2 cells. 
Overexpression of CDO in C2C12 cells accelerates dif-
ferentiation, while expression of secreted soluble extra-
cellular regions of CDO inhibits this process. Onco-
genic Ras is known to block differentiation of C2C12 
cells via downregulation of MyoD. Reexpression of 
CDO in C2C12/Ras cells induces MyoD; conversely, 
MyoD induces CDO. Reexpression of either CDO or 
MyoD rescues differentiation of C2C12/Ras cells with-
out altering anchorage-independent growth or morpho-
logical transformation. CDO and MyoD are therefore 
involved in a positive feedback loop that is central to 
the inverse relationship between cell differentiation 
and transformation. It is proposed that CDO mediates, 
at least in part, the effects of cell–cell interactions be-
tween muscle precursors that are critical in myogenesis.
Key words: myogenesis • MyoD • CDO • Ras • cell 
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I
 
n
 
 vertebrates, the skeletal muscles of the trunk and
limbs arise from the somites. Somites develop from
unsegmented paraxial mesoderm as spheres of colum-
nar epithelial cells that mature into distinct cellular com-
partments in response to signals from surrounding tissues
(for reviews see Christ and Ordahl, 1995; Lassar and Mun-
sterberg, 1996). The ventral half of the somite develops
into the sclerotome, which has a mesenchymal morphol-
ogy and ultimately gives rise to vertebrae and ribs. The
dorsal region retains an epithelial morphology and com-
prises the dermomyotome, which gives rise to skeletal
muscle and dermis. The dermomyotomal cells adjacent to
the neural tube form the myotome, a layer of differenti-
ated muscle cells positioned between the dermomyotome
and sclerotome. The generation of myogenic cells in the
somite is regulated by signals derived from neighboring
axial tissues (neural tube and notocord), including Wnt
family members and Sonic hedgehog, or by less well-
defined signals derived from surface ectoderm (Munster-
berg et al., 1995; Stern et al., 1995; Cossu et al., 1996).
Determination and differentiation of cells in the skeletal
muscle lineage also requires specific but poorly under-
stood cell–cell interactions between muscle precursors,
known as the community effect (Gurdon, 1988; Cossu et
al., 1995). The cell surface molecules that mediate the
community effect are largely unknown, although cad-
herins are likely to play a role (Holt et al., 1994; George-
Weinstein et al., 1997; Redfield et al., 1997).
The earliest known markers that are specific for the
skeletal muscle lineage are the four myogenic basic helix-
loop-helix (bHLH)
 
1
 
 factors MyoD, myogenin, Myf-5, and
MRF4 (for reviews see Ludolph and Konieczny, 1995;
Molkentin and Olson, 1996; Molkentin and Olson, 1996;
Yun and Wold, 1996). These proteins function in both de-
termination and differentiation of cells in this lineage and
share the remarkable property of being able to activate
the myogenic program in a variety of non-muscle cell
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types (Weintraub et al., 1989). During differentiation,
myogenic bHLH factors activate muscle-specific genes
and coordinate withdrawal from the cell cycle. They are
also targets of growth factor–signaling pathways that nega-
tively regulate myogenic differentiation (Ludolph and Ko-
nieczny, 1995; Molkentin and Olson, 1996; Molkentin and
Olson, 1996; Yun and Wold, 1996).
In cell culture systems, myogenic bHLH factors autoac-
tivate and cross-activate each other’s expression, which
likely amplifies and maintains the myogenic phenotype
(Ludolph and Konieczny, 1995; Molkentin and Olson,
1996
 
a
 
; Molkentin and Olson, 1996
 
b
 
; Yun and Wold, 1996).
Also present in the regulatory regions of many muscle-
specific genes are sequences that bind myocyte enhancer
binding factor-2 (MEF-2) family proteins (Olson et al.,
1995). Although MEF-2 factors do not activate myogene-
sis alone, they interact physically and genetically with
myogenic bHLH factors to do so (Molkentin and Olson,
1996
 
a
 
; Molkentin and Olson, 1996
 
b
 
; Yun and Wold, 1996).
Proteins other than myogenic bHLH factors therefore
play a role in the positive feedback mechanisms that regu-
late the myogenic lineage, which raises the possibility that
molecules that participate in the effects of cell–cell inter-
actions during myogenesis could also be components of
this network of regulatory proteins.
Myogenesis serves as a useful model to understand the
relationship between differentiation and oncogenesis. A
variety of oncogenes and growth factors inhibit differenti-
ation of cultured myoblasts via multiple mechanisms, in-
cluding transcriptional downregulation of genes encoding
myogenic bHLH factors and posttranslational inhibition
of these factors’ myogenic activity (Olson, 1992). Impor-
tantly, although cell proliferation and differentiation are
usually mutually exclusive, the transformation- and growth
factor–mediated blockade of differentiation of myoblasts
is not simply a consequence of maintaining the cells in a
proliferative state, since this inhibition can occur in the ab-
sence of cell division (Spizz et al., 1986; Olson et al., 1987).
We have recently described a novel member of the Ig
superfamily, designated CDO (for CAM-related/down-
regulated by oncogenes; Kang et al., 1997). CDO is a
member of a recently identified subfamily characterized
by an extracellular region that contains five Ig-like repeats
followed by three fibronectin type III (FNIII)-like repeats,
a transmembrane segment, and a long cytoplasmic tail.
The other members of this 5 
 
1
 
 3 subfamily are the Robo-
like receptors, which are all more closely related to each
other than to CDO (Kidd et al., 1998; Zallen et al., 1998).
Multiple lines of evidence indicate that the Robo proteins,
of which one has been identified in 
 
C
 
.
 
 elegans
 
, and two
each in 
 
Drosophila
 
, rat, and human, are evolutionarily
conserved axon guidance molecules, most likely serving as
receptors for a CNS midline repellent (Kidd et al., 1998;
Zallen et al., 1998). Rat, mouse, and human forms of CDO
have been isolated, but no function for these proteins has
yet been described.
 
cdo
 
 is expressed at very low levels in adult rat tissues,
but at high levels in rat embryo fibroblasts (Kang et al.,
1997). 
 
cdo
 
 is transcriptionally downregulated by a variety
of oncogenes (Kang et al., 1997), many of which are
known to inhibit myogenic differentiation (Olson, 1992).
We report here that 
 
cdo
 
 is expressed at high levels during
 
murine embryogenesis in somites, dermomyotome, and
myotome, as well as in myoblast cell lines. Overexpression
of CDO in myoblasts accelerates differentiation, while ex-
pression of secreted soluble forms of CDO block this pro-
cess. Oncogenic Ras inhibits myogenic differentiation in a
fashion dependent on loss of CDO expression, while other
aspects of the transformed phenotype such as anchorage-
independent growth, are independent of CDO. Thus,
CDO is a cell surface protein that plays an important role
in myogenic differentiation. We propose that CDO is in-
volved in regulating cell–cell interactions between muscle
precursors that are critical in myogenesis. Furthermore,
these results establish that members of the 5 
 
1
 
 3 subfamily
regulate diverse processes that contribute to morphogene-
sis and differentiation.
 
Materials and Methods
 
Isolation of a Mouse cdo cDNA
 
A mouse 
 
cdo
 
 cDNA comprising 90 bp of the 5
 
9
 
 UTR, the full open read-
ing frame, and 122 bp of the 3
 
9
 
UTR was isolated by screening a mouse
E10.5 lambda gt11 cDNA library (kindly provided by T. Lufkin, Mount
Sinai School of Medicine) with rat 
 
cdo
 
 as a probe. The amino acid se-
quence of mouse CDO is 94% identical and 98% similar to rat CDO, and
is 83% identical and 93% similar to human CDO. The GenBank accession
number for mouse 
 
cdo
 
 is AF090866.
 
In Situ Hybridization
 
The mouse 
 
cdo
 
 cDNA described above was subcloned into pBluescript
KS(
 
2
 
). This plasmid was linearized, and an anti-sense riboprobe compris-
ing 122 nucleotides of 3
 
9
 
 UTR and the COOH-terminal 2322 nucleotides
was generated by transcribing from the T7 promoter in the presence of
 
35
 
S- or digoxygenin-labeled nucleotides (used for thin section or whole
mount in situ hybridizations, respectively). A control sense riboprobe did
not generate any signal. Thin-section in situ hybridization was performed
as previously described (Sassoon and Rosenthal, 1993). Whole-mount in
situ hybridization was performed as described by Henrique et al. (1995),
with a slight modification of the bleaching step (6% hydrogen peroxide/
0.1% Tween 20/PBS for 1 h at room temperature). 
 
Cell Culture
 
C2C12 cells (Blau et al., 1983) were cultured in DMEM plus 15% FBS
(growth medium, GM). Cells were induced to differentiate at 80–90%
confluence by transferring them into DMEM plus 2% horse serum (differ-
entiation medium, [DM]). C2C12(E) cells were provided by D. Vassilatis
(Merck Research Laboratories, Rahway, NJ), who received them directly
from H. Blau (Stanford University). C2C12(E) cells and the aza-myoblast
lines P2 and F3 (Davis et al., 1987) were cultured as described above.
10T1/2 cells were cultured in DMEM plus 10% FBS. Production of re-
combinant retroviruses and infection of cell lines with pBabePuro (Mor-
ganstern and Land, 1990) and pBabePuro/
 
cdo
 
 was performed as described
in Kang et al. (1997). Myc-tagged 
 
myoD
 
 and 
 
myogenin
 
 cDNAs (kindly
supplied by A. Lassar; Harvard Medical School) and mouse 
 
cdo
 
 were also
inserted into pBabePuro for production of recombinant viruses. Infected
cultures were selected in medium that contained 5 
 
m
 
g of puromycin per
ml. Soft agar assays and preparative methylcellulose cultures were per-
formed as described in Kang and Krauss (1996). 
 
RNA and Protein Analyses
 
Total cellular RNA was isolated with the TRIzol reagent (Life Technolo-
gies, Gaithersburg, MD) according to the manufacturer’s instructions.
Northern blot analyses were performed by fractionating total cellular
RNA through agarose-formaldehyde gels, blotting to nylon membranes,
and hybridizing with DNA probes as described by Krauss et al. (1992).
 
myoD
 
 (Davis et al., 1987), 
 
myogenin
 
 (Wright et al., 1989) and 
 
myf-5
 
probes (Ott et al., 1991) were used.
Immunoblot analyses were performed essentially as described in Kang 
Kang et al. 
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et al. (1997). Cultures were harvested in lysis buffer (10 mM Tris-HCl, pH
7.2/150 mM NaCl/1% Triton X-100/1% sodium deoxycholate/0.1% SDS/1
mM EGTA) containing 1 mM PMSF, 10 ng/ml leupeptin, 50 mM NaF,
and 1 mM sodium orthovanadate. Total proteins were then separated on
SDS-polyacrylamide gels, transferred to nitrocellulose membranes (Am-
ersham Life Science, Inc., Arlington Heights, IL), and the membranes
were probed with one of the following antibodies from the indicated
source: anti-myosin heavy chain (MHC) (MF20; Bader et al., 1982); anti-
troponin T (TnT; Sigma Chemical Co., St. Louis, MO); anti-MyoD (Santa
Cruz Biotechnology, Santa Cruz, CA); anti-myogenin (F5D; Wright et al.,
1996); and anti-CDO (Kang et al., 1997). After extensive washing (with 40
mM Tris-HCl, pH 8.0/50 mM NaCl/1 mM EDTA), the blots were re-
probed with horseradish peroxidase–conjugated secondary antibody, and
specific protein bands were visualized with the ECL chemiluminescent de-
tection system (Amersham Life Science, Inc.). Immunostaining for MHC
was performed with the monoclonal antibody MF20 as described by
Bader et al. (1982). After sequential incubation with biotinylated goat
anti–mouse IgG and peroxidase-conjugated streptavidin, cells were
stained with 3,3
 
9
 
-diaminobenzidine (Sigma Chemical Co.).
 
CDO Fusion Proteins
 
A PCR-derived fragment containing the signal sequence and entire extra-
cellular region of rat CDO was subcloned into the Aptag-2 or Igtag vec-
tors (Bergemann et al., 1995) to produce CDO-alkaline phosphatase (AP)
and CDO-Fc, respectively. These vectors, which place the fusion proteins
under the transcriptional control of the cytomegalovirus promoter, were
transfected into C2C12(E) cells by the calcium phosphate technique
(Wigler et al., 1978). 10 
 
m
 
g of each vector was cotransfected with 1 
 
m
 
g of
pBabePuro, and cultures were selected in medium containing 5 
 
m
 
g puro-
mycin per ml. Aptag-4, which encodes a secreted soluble form of AP it-
self, was used as a control. Secretion of CDO-AP and AP into the medium
of selected cultures was determined by colorimetric assay of AP activity in
conditioned medium (CM) as described by Flanagan and Leder (1990).
Production of CDO-Fc was determined by immunoprecipitation of CM
with protein A-Sepharose, followed by immunoblot analysis of eluted
proteins with peroxidase-coupled goat anti–human IgG.
To assess the differentiation capacity of cells that secreted these pro-
teins into their medium, we wished to avoid transferring the cells into DM,
because that would remove the secreted protein at the same time the cells
received the differentiation signal. Instead, cells were plated in GM, and
were then held to allow the medium to become depleted of growth fac-
tors. Untransfected and AP-expressing C2C12(E) cells differentiated very
efficiently under these conditions (see Results).
 
Results
 
cdo Expression in Early Myogenic Precursors
 
Previous studies determined that 
 
cdo
 
 mRNA is expressed
at extremely low levels in adult tissues (Kang et al., 1997).
Since many other members of the Ig/FNIII family, includ-
ing Robo, are expressed and function during development,
 
cdo
 
 mRNA expression during murine embryogenesis was
assessed by whole-mount and thin section in situ hybrid-
ization. 
 
cdo
 
 is expressed in a variety of tissues in a broad
and complex pattern (P.J. Mulieri, D.A. Sasson, and R.S.
Krauss, unpublished results). The most striking expression
is seen in the somites and neural tube. As early as E8.5,
both the somites and dorsal lips of the neural tube express
high levels of 
 
cdo
 
 mRNA (Fig. 1 
 
A
 
). The somitic expres-
sion coincides with formation of the epithelialized somite
since no expression was detected in unsegmented paraxial
mesoderm. All somites were positive for 
 
cdo
 
 expression as
late as E11.5 (data not shown). Thin-section in situ hybrid-
ization demonstrated that 
 
cdo
 
 expression is restricted to
the dorsal region of the epithelialized somite (data not
shown), and is maintained in both the dermomyotome and
myotome as the somites matured (Fig. 1, 
 
B
 
–
 
E
 
). The obser-
vation of robust expression of 
 
cdo
 
 in the early myogenic
compartment suggests a function during determination or
differentiation of cells in the myogenic lineage. To investi-
gate this possibility further, studies on CDO expression
and function were performed with the well-characterized
C2C12 myoblast cell line. 
 
CDO Levels are Regulated during C2C12
Myoblast Differentiation
 
C2C12 myoblasts proliferate in serum-rich GM, but when
cultured at a high cell density in mitogen-deficient DM
they withdraw from the cell cycle, express muscle-specific
genes, and fuse to form multinucleate myotubes (Blau et
al., 1983). Under the conditions used in this study, these
cells expressed detectable levels of myogenin 24 h after
the shift to DM, and produced MHC 24 h after that (Fig.
2). Myotubes began to form 2 d after transfer to DM, and
the majority of cell nuclei were present in large multinu-
cleate myotubes after 4 d in DM. C2C12 cells cultured in
GM expressed 
 
cdo
 
 mRNA and protein regardless of cell
density (Fig. 2, lane 
 
1
 
; and data not shown). The levels of
both the mRNA and protein were transiently but repro-
ducibly increased about twofold 48 h after the cells were
Figure 1. Expression of cdo
in the early myogenic com-
partment of the developing
mouse. (a) Whole-mount in
situ hybridization of an E8.5
embryo showing strong ex-
pression of cdo in the dorsal
neural tube (arrows) and
somites (arrowheads). Ex-
pression is present in the
most recently formed so-
mites, and is maintained as
somites develop, but is ab-
sent in unsegmented paraxial
mesoderm. (b and c) In situ
hybridization of a sectioned E10.5 embryo showing regional expression of cdo in somites. (b) Bright-field image; (c) dark-field images.
(d and e) Bright-field (d) and dark-field (e) images of the same section shown in b and c shown at higher magnification. Note that cdo
is expressed at high levels in the dermomyotome (arrowheads) and myotome (arrows), but is absent from sclerotome (* in d). 
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transferred into DM (Fig. 2). Interestingly, after 4 d in DM
when the cultures were fully differentiated, CDO protein,
but not mRNA, was dramatically downregulated (Fig. 2).
We have previously demonstrated that, in Rat 6 fibro-
blasts, CDO is posttranscriptionally regulated by cell–
substratum adhesion (Kang et al., 1997). It is possible,
therefore, that differentiation-mediated alterations in the
repertoire of extracellular matrix molecules and receptors
expressed by C2C12 cells plays a role in this phenomenon
(McDonald et al., 1995). 
 
Overexpression of CDO Induces Precocious 
Differentiation of C2C12 Cells
 
To investigate the function of CDO during myoblast dif-
ferentiation, C2C12 cells were engineered to overexpress
CDO. C2C12 cells were infected with control or 
 
cdo
 
-
expressing retroviruses and selected for puromycin resis-
tance; drug-resistant colonies were pooled and examined
for expression of CDO and their ability to differentiate.
The 
 
CDO
 
 virus-infected cells (C2C12/CDO cells) dis-
played a two- to threefold increase in CDO protein above
the endogenous level produced by control infectants
(C2C12/puro cells; Fig. 3 
 
a
 
). Overproduction of CDO had
no effect on the morphology of C2C12 cells, or on their
ability to proliferate in GM (data not shown). When chal-
lenged to differentiate, C2C12/puro cells closely resem-
bled the parental line, exhibiting only a few small MHC-
positive myotubes after 2 d in DM (Fig. 3 
 
b
 
). In contrast,
C2C12/CDO cells formed many large MHC-positive myo-
tubes at the same time point (Fig. 3 
 
b
 
). The extent of myo-
genesis was quantitated by determining the percentage of
nuclei present in myotubes. 2 d after the shift to DM, 17%
of C2C12/puro cell nuclei were found in myotubes,
whereas 59% of C2C12/CDO cell nuclei were in myotubes
(average values determined from four experiments). Con-
sistent with these results, expression of MHC and TnT was
increased in C2C12/CDO cells relative to C2C12/puro
cells as determined by Western blot analysis of cells cul-
tured in DM for 2 d (Fig. 3 
 
c
 
). However, expression of
MyoD and myogenin were not increased by overexpres-
sion of CDO (Fig. 3 
 
c
 
). After 4 d in DM, cultures of both
cell types looked very similar with 
 
z
 
80% of their nuclei
present in myotubes. Thus, overexpression of CDO re-
sulted in precocious morphological and biochemical dif-
ferentiation of C2C12 cells. Similar data were obtained
when CDO was overexpressed in P2 cells, a myoblast line
derived by treatment of 10T1/2 cells with 5-azacytidine
(Davis et al., 1987), indicating that the effects of CDO
were not restricted to C2C12 cells (data not shown).
Because C2C12 is a long-established cell line, the effects
of CDO overexpression were also investigated in an addi-
tional strain of C2C12 cells (here designated C2C12[E]).
The major differences between C2C12(E) cells and the
strain of C2C12 cells described above are that: (
 
a
 
) the
former cells expressed detectable levels of myogenin be-
fore the shift into DM; and (
 
b
 
) all the events described in
Fig. 2 occurred over 2 d instead of 4 (data not shown).
Overexpression of CDO by two to threefold above endog-
enous levels (Fig. 3 
 
a
 
) led to a striking phenotype in the
C2C12(E) cells: these cells formed myotubes even when
cultured at subconfluence in GM, a condition under which
the parental or control virus–infected cells were unable to
do so (Fig. 3 
 
b
 
). As might be predicted, this phenotype was
not stable. Continued passage of C2C12(E)/CDO cells re-
sulted in a population of cells that displayed accelerated
differentiation in DM, but no longer formed myotubes in
GM. Thus, overexpression of CDO in highly differentia-
tion-proficient cells was able to override the inhibitory ef-
fects of serum on myotube formation transiently. 
 
Downregulation of CDO Is Required for Ras-mediated 
Inhibition of Myogenic Differentiation
 
CDO was originally identified as a gene whose expression
was downregulated by v-H-
 
ras 
 
and other oncogenes (Kang
et al., 1997). Oncogenic Ras blocks differentiation of
C2C12 and other myoblast cell lines by multiple mecha-
nisms, including downregulation of 
 
myoD
 
 and 
 
myogenin
 
expression and posttranslational inhibition of the activity
of myogenic bHLH factors (Konieczny et al., 1989; Lassar
et al., 1989; Kong et al., 1995). Furthermore, forced reex-
pression of MyoD in Ras-transformed C2C12 cells led to
reexpression of endogenous MyoD and myogenin, and
rescued the ability of the transformed cells to differentiate
(Konieczny et al., 1989; Lassar et al., 1989). We therefore
examined the pattern of CDO expression in Ras-trans-
formed C2C12 cells, as well as the effects of forced expres-
sion of CDO on such cells. C2C12(E) cells were infected
with either control or v-H-
 
ras
 
-expressing retroviruses, and
were selected for G418 resistance followed by infection
with control or 
 
cdo
 
-expressing retroviruses and selection
for puromycin resistance. Three cell lines were then used
Figure 2. Expression of CDO in C2C12 myoblasts during differ-
entiation. C2C12 myoblasts were grown to near confluence,
shifted into DM, and harvested at the indicated time points. The
upper panel shows a Northern blot analysis of cdo mRNA ex-
pression. The ethidium bromide–stained gel, displaying the 28S
and 18S ribosomal RNA bands, is shown as a loading control.
The lower panel shows Western blot analyses of CDO, myoge-
nin, and MHC expression as indicated. 
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for further study: C2C12/neo/puro, a double infection con-
trol; C2C12/Ras/puro, a transformed cell line; and C2C12/
Ras/CDO, a cell line that expresses both oncogenic Ras
and exogenous CDO. These cells were analyzed for ex-
pression of muscle-specific genes at the mRNA and pro-
tein levels, for the ability to differentiate, and for transfor-
mation-related phenotypes.
As expected, Ras led to downregulation of both MyoD
and myogenin, although a detectable level of MyoD per-
sisted (Fig. 4, 
 
a
 
 and 
 
b
 
). CDO was also strongly downregu-
lated by Ras at both the mRNA and protein levels (Fig. 4,
 
a
 
 and 
 
b
 
). Furthermore, C2C12/Ras/puro cells did not ex-
press the muscle structural proteins MHC and TnT (Fig. 4
 
b
 
), nor did they form myotubes (Fig. 4 
 
c
 
), even when cul-
tured in DM. In contrast to the other muscle markers,
 
myf-5 
 
mRNA, which was expressed at a much lower level
than the other two myogenic bHLH factors, was not regu-
lated by either Ras or culture conditions (Fig. 4 
 
a
 
).
The forced reexpression of CDO in C2C12/Ras/CDO
cells led to a corresponding reexpression of endogenous
MyoD and myogenin and, when these cells were shifted to
DM, induction of MHC and TnT was restored (Fig. 4, 
 
a
 
and 
 
b
 
). Furthermore, C2C12/Ras/CDO cells formed myo-
tubes in DM, although these myotubes were smaller and
less abundant than those found in parental C2C12 cells or
any control virus-infected derivative (Fig. 4 c). It should be
emphasized that C2C12/Ras/CDO cells produced a level
of CDO protein that was comparable to the endogenous
level seen in control C2C12/neo/puro cells. Furthermore,
C2C12/Ras/CDO cells reexpressed MyoD, myogenin, MHC,
and TnT at levels only slightly lower than those seen in the
control cells. They also expressed abundant Ras protein,
equivalent to the level seen in C2C12/Ras/puro cells (Fig.
4 b). Finally, it should be noted that under these condi-
tions (4 d after transfer to DM) there was no difference in
the extent of differentiation between control C2C12(E)
cells and C2C12(E) cells that overexpressed CDO (data
not shown). Similar to MyoD, therefore, reexpression of
Figure 3. Overexpression of
CDO enhances differentia-
tion of C2C12 myoblasts.
C2C12 or C2C12(E) cells
were infected with recombi-
nant pBabePuro/cdo virus or
pBabePuro virus lacking a
cDNA insert, selected for re-
sistance to puromycin, and
analyzed for expression of
CDO, myotube formation,
and expression of muscle-
specific proteins. (a) Western
blot analysis of CDO expres-
sion by infectants. (2) Infec-
tion with control pBabePuro
virus; (1), infection with
pBabePuro/cdo virus. (b) Photomicrographs of infectants. The two panels on the left show cultures of C2C12 infectants stained with a
monoclonal antibody to MHC after 2 d in DM. The two panels on the right show phase-contrast micrographs of C2C12(E) cell infec-
tants cultured in GM. Note that the CDO-overexpressing C2C12(E) cells form myotubes in GM, while the control C2C12(E) infectants
do not. Bar, 250 mm. (c) Western blot analyses of muscle-specific proteins expressed by C2C12 cell infectants cultured in G or D me-
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CDO is capable of reestablishing the differentiation pro-
gram in Ras-transformed myoblasts.
CDO, Like MyoD, Fails to Revert Other Aspects of the 
Transformed Phenotype
Expression of oncogenic Ras in C2C12 cells leads not only
to a block in differentiation, but also to additional re-
sponses characteristic of the transformed phenotype; e.g.,
anchorage-independent growth and morphological alter-
ations (Olson et al., 1987; Lassar et al., 1989). Forced
expression of MyoD in Ras-transformed C2C12 cells reac-
tivated differentiation, but did not interfere with anchor-
age-independent growth of the cells (Lassar et al., 1989).
We therefore tested the effects of exogenous CDO expres-
sion on additional properties of Ras-transformed C2C12
cells. To assess anchorage-independent growth, C2C12/
neo/puro, C2C12/Ras/puro, and C2C12/Ras/CDO cells were
each cultured in soft agar. As expected, C2C12/neo/puro
cells failed to form progressively growing colonies, while
21% of the C2C12/Ras/puro cells formed large colonies
(.0.3-mm diameter). Interestingly, the C2C12/Ras/CDO
cells behaved very similarly to the C2C12/Ras/puro cells,
also forming colonies with an efficiency of 21%. Culturing
Rat 6 fibroblasts in suspension leads to posttranscriptional
downregulation of CDO (Kang et al., 1997). To determine
whether the ability of C2C12/Ras/CDO cells to form colo-
nies in soft agar was due simply to loss of stable produc-
tion of CDO protein, cells were cultured either on plastic
dishes or in medium containing 1.3% methylcellulose,
which permits nearly quantitative recovery of suspended
cells (Kang and Krauss, 1996). Such cultures were then an-
alyzed by Western blotting with antibodies to CDO. As
can be seen in Fig. 5 a, loss of cell substratum adhesion did
not result in loss of CDO protein production in C2C12/
Figure 4. CDO reactivates the differentiation program in C2C12/
Ras cells. C2C12(E) cells were infected with recombinant retrovi-
ruses harboring v-H-ras or cdo (1), or with control viruses (2) as
indicated and as described in the text. Cultures were analyzed by
Northern and Western blotting techniques and by microscopy.
(a) Northern blot analyses of cdo, myf-5, myoD, and myogenin
expression in various infectants cultured in G or D medium. The
ethidium bromide–stained gel displaying the 28S and 18S riboso-
mal RNA bands is shown as a loading control. Note that the en-
dogenous and exogenous cdo mRNAs are almost identical in
size. The myf-5 blot was exposed to film approximately sixfold
longer than the other blots. (b) Western blot analyses of Ras,
CDO, MyoD, myogenin, MHC, and TnT levels in various infec-
tants cultured in G or D medium. The identity of the lower band
in the CDO panel is unknown, but is not CDO. The reason for
the downregulation of endogenous MyoD protein in C2C12/Ras/
CDO cells cultured in D medium is not clear, but is not seen with
the control infectants. Downregulation was also observed in
C2C12/Ras cells that expressed exogenous MyoD (see Fig. 6).
The expression of low levels of MHC and TnT in the control in-
fectants cultured in G medium (the first lane in B) was due to the
high density of these cells when harvested. (c) Phase-contrast
photomicrographs of C2C12/Ras/puro and C2C12/Ras/CDO cells
cultured in DM. Note the presence of myotubes in the latter, but
not the former cells. Because the Ras-expressing cells are poorly
adherent and grow to high density in multiple layers, some cells
in each micrograph inevitably appear out of focus. Bar, 250 mm. Kang et al. CDO Mediates Myogenic Differentiation 409
Ras/CDO cells. The ability of these cells to form colonies
in soft agar was therefore not due to a failure to produce
CDO when cultured in semisolid medium.
C2C12/Ras/puro cells also displayed a typical trans-
formed morphology: the cells were spindly, highly refrac-
tile, and disorganized when compared with control C2C12
cells (Fig. 3 b and Fig. 5 b). Interestingly, C2C12/Ras/CDO
cells maintained a transformed morphology. C2C12/Ras cells
that expressed retrovirally-encoded MyoD (see below for
a description of these cells) were slightly less rounded than
C2C12/Ras/puro cells, but remained highly refractile and
disorganized (Fig. 5 b). Similar to the results of Lassar et
al. (1989), these cells formed colonies in soft agar with a
frequency of 22%. Forced reexpression of CDO or MyoD
in Ras-transformed C2C12 cells therefore resulted in very
similar phenotypes. Both genes restored the ability of the
cells to differentiate without significantly affecting their
highly altered morphology or anchorage-independent
growth (Lassar et al., 1989 and see below). 
Reexpression of MyoD in C2C12/Ras Cells
Induces CDO
One possible interpretation of the striking similarity of the
response of C2C12/Ras cells to exogenous CDO or MyoD
is that CDO can act as an upstream inducer of myoD and
myogenin expression. The known autoregulatory activity
of myogenic bHLH factors suggests an additional nonmu-
tually exclusive possibility: that CDO is an integral part of
a positive feedback network that controls myogenic differ-
entiation, and is itself regulated by the myogenic program.
To address this question, we expressed myc-tagged MyoD
in C2C12/Ras cells via retroviral infection, and tested the
cells for expression of CDO by Western blot analysis. As
reported previously (Lassar et al., 1989) and as shown in
Fig. 6 a, expression of exogenous MyoD (MyoD* in Fig. 6
a) induced endogenous MyoD, and when the cells were
cultured in DM, induced the muscle structural protein
TnT. Interestingly, forced expression of MyoD in C2C12/
Ras cells led to expression of endogenous CDO (Fig. 6 a),
suggesting the possible existence of a positive feedback
Figure 5. CDO does not revert anchorage-independent growth
or morphological transformation of C2C12/Ras cells. (a) Expres-
sion of CDO by C2C12/Ras/CDO cells is not lost when the cells
are cultured in suspension. Western blot analysis of CDO expres-
sion is shown for the indicated infectants when cultured on plas-
tic dishes (1 adhesion) or in methylcellulose-containing medium
(2 adhesion). (b) Phase-contrast photomicrographs of C2C12/
Ras/puro, C2C12/Ras/CDO, and C2C12/Ras/MyoD cells cul-
tured in GM. Bar, 250 mm.  Figure 6. Stable expression of MyoD induces CDO. (a) Western
blot analyses of MyoD, CDO, and TnT expression is shown for
the indicated infectants cultured in G or D medium. MyoD* indi-
cates retrovirally encoded myc-tagged MyoD; MyoD indicates
endogenous protein. (b) Western blot analysis of CDO, MyoD,
and MHC expression in various 10T1/2 cell derivatives. 10T1/2
refers to the parental line; 10T1/2/puro and 10T1/2/CDO are lines
stably infected with control or cdo retrovirus, respectively; and P2
and F3 are myoblast lines derived by treatment of 10T1/2 cells
with 5-azacytidine (Davis et al., 1987). CDO expression was ana-
lyzed in cells cultured in GM; MyoD and MHC expression was
analyzed in cells cultured for 3 d in DM. The Journal of Cell Biology, Volume 143, 1998 410
loop between CDO and myogenic bHLH factors. We also
attempted to express myogenin exogenously in C2C12/
Ras cells, but were unable to select cells that produced
more than trace levels of this protein, possibly because
they differentiated prematurely. Nevertheless, the cells
that made a low level of myogenin also restored a small
amount of CDO expression (data not shown).
The murine embryo fibroblast cell line 10T1/2 can be
converted to MyoD-expressing myoblasts by treatment
with the DNA demethylating agent 5-azacytidine (Taylor
and Jones, 1979; Davis et al., 1987). 10T1/2 cells expressed
barely detectable levels of CDO, but two independent
5-azacytidine-induced myoblast lines (P2 and F3) ex-
pressed abundant CDO (Fig. 6 b). Taken together, the
data presented in Fig. 6 suggest that cdo expression may
be regulated in part by the myogenic program. However,
unlike the four known myogenic bHLH factors, ectopic
expression of CDO in 10T1/2 cells (Fig. 6 b) was not suffi-
cient to convert these cells to the myogenic phenotype, as
measured by expression of muscle-specific genes (Fig. 6 b)
or myotube formation (data not shown).
Secreted Soluble CDO Inhibits C2C12
Cell Differentiation
Most members of the Ig/FNIII family bind in homo- or
heterophilic fashion to cell surface proteins on adjacent
cells (Brummendorf and Rathjen, 1995). Although CDO
does not appear to mediate cell–cell adhesion (Kang et al.,
1997), recombinant soluble fusion proteins that contain
the entire CDO extracellular region coupled to either al-
kaline phosphatase (AP) or the Fc region of human IgG
(CDO-AP and CDO-Fc, respectively; Fig. 7 a) bound to
the surface of various cell types (data not shown). We rea-
Figure 7. Secreted, soluble forms of CDO inhibit myogenic differentiation. (a) Schematic representation of CDO and the soluble fusion
proteins CDO-AP and CDO-Fc. C2C12(E) cells were stably transfected with expression vectors for CDO-AP, CDO-Fc, or secreted AP
itself, and were analyzed as described below. (b) Photomicrographs of cells expressing secreted AP or CDO-AP were cultured under
differentiation-inducing conditions and stained with a monoclonal antibody to MHC. Bar, 250 mm. (c) Western blot analyses of MyoD,
myogenin, MHC, and TnT expression in cells expressing the indicated vector cultured for the indicated times under differentiation-
inducing conditions (see Materials and Methods for details). (d) Western blot analysis of CDO-Fc in CM from stably transfected
C2C12(E) cells and transiently transfected 293T cells.Kang et al. CDO Mediates Myogenic Differentiation 411
soned that if CDO exerts its positive effects on myogenic
differentiation via interaction with another protein(s) on
neighboring cells, soluble CDO fusion proteins might
compete with endogenous membrane-bound CDO and
block differentiation. To test this hypothesis, C2C12(E)
cells were stably transfected with expression vectors for
CDO-AP, CDO-Fc, and, as a control, secreted AP alone.
AP activity was easily detected in the conditioned medium
(CM) of the CDO-AP and AP transfectants (data not
shown), and CDO-Fc was detected immunologically in
CM from the CDO-Fc transfectants (Fig. 7 d). These cells
were then assessed for their ability to differentiate.
As shown in Fig. 7 b, cells that expressed AP differenti-
ated robustly (49% of nuclei present in MHC-positive
cells, which were mainly myotubes). In contrast, cells that
expressed either of the CDO fusion proteins differentiated
poorly under the same conditions (12% of nuclei in MHC-
positive cells, which were almost exclusively myocytes;
Fig. 7 b and data not shown). Consistent with this result,
Western blot analyses demonstrated that expression of
CDO-AP or CDO-Fc delayed accumulation of the differ-
entiation markers myogenin, MHC, and TnT (Fig. 7 c). As
was observed with CDO overexpression (Fig. 3 c), how-
ever, inhibition by CDO-AP or CDO-Fc was not accom-
panied by alterations in the levels of MyoD (Fig. 7 c). Ex-
pression of CDO-AP or CDO-Fc also did not significantly
alter the levels of endogenous CDO (data not shown).
Comparable results were obtained when CM from 293T
cells that had been transiently transfected with CDO-Fc
were added to cultures of naive C2C12(E) cells, but not
when CM from mock-transfected cells was used (data not
shown; see Fig. 7 d for production of CDO-Fc by 293T
cells). The inhibition of differentiation by soluble CDO fu-
sion proteins was transient in nature; after several days un-
der differentiation-inducing conditions, the cultures that
expressed CDO-AP or CDO-Fc expressed muscle struc-
tural proteins, and had formed MHC-positive myotubes to
nearly the extent observed with the AP-expressing cells
(Fig. 7 c and data not shown). Expression of soluble se-
creted CDO fusion proteins therefore significantly de-
layed, but did not ablate, differentiation. This result is con-
sistent with the notion that soluble CDO exerted its effects
in these cells by competition with endogenous CDO.
To confirm that inhibition of CDO function interferes
with differentiation, C2C12(E) cells were infected with a
retrovirus harboring a murine cdo cDNA in the anti-sense
orientation, or a control virus that lacked a cDNA insert.
Puromycin-resistant colonies were selected, shifted to DM
for 3 d, and the percentage of colonies bearing myotubes
was scored. Approximately 68% of the colonies infected
with the control retrovirus contained myotubes, whereas
only 33% of the colonies infected with the anti-sense cdo-
expressing virus formed myotubes. Taken together, these
data indicate that endogenous CDO plays an important,
possibly critical, role in myoblast differentiation.
Discussion
CDO Mediates Myogenic Differentiation
We report here that CDO, a member of the 5 1 3 subfam-
ily of Ig/FNIII repeat–containing cell surface proteins
plays a key role in myogenic differentiation. This conclu-
sion is based on the observations that overexpression of
CDO enhances differentiation of myoblast cell lines; that
expression of soluble secreted forms of CDO or antisense
cdo vectors inhibit differentiation; and that Ras inhibits
differentiation of myoblasts in a manner dependent on
downregulation of CDO. Additionally, overexpression of
CDO in early passage, highly differentiation-proficient
C2C12(E) myoblasts was sufficient to promote myotube
formation in GM. CDO is the only protein other than a
myogenic bHLH factor able to override a serum- or onco-
gene-induced block to myogenesis reported to date.
The enhancement or inhibition of differentiation in-
duced by wild-type or soluble CDO, respectively, occurs
without detectable alterations in the levels of MyoD.
These data suggest that CDO may function by increasing
the activity of MyoD at a posttranslational level. In con-
trast, reexpression of CDO in C2C12/Ras cells led to in-
duction of myoD at the mRNA level. It is worth noting
that C2C12/Ras cells retain low levels of MyoD and Myf-5,
which are presumably kept inactive by poorly understood
posttranslational mechanisms (Lassar et al., 1989; Kong et
al., 1995). One possible explanation for these results is that
CDO overrides or reverses Ras-mediated inhibition of the
remaining low levels of MyoD and Myf-5, leading to acti-
vation of the positive feedback loops that regulate expres-
sion of myogenic bHLH factors and MEF-2. After a criti-
cal threshold concentration of these proteins is achieved,
the ability to differentiate could be reimposed, even in the
presence of activated Ras.
This feedback mechanism is thought to amplify and
maintain differentiation signals (Ludolph and Konieczny,
1995; Molkentin and Olson, 1996; Molkentin and Olson,
1996; Yun and Wold, 1996). It is therefore interesting that
expression of exogenous CDO in C2C12/Ras cells led to
induction of MyoD and myogenin, and, conversely, ex-
pression of exogenous MyoD in these cells led to induc-
tion of CDO. These results indicate that a positive feed-
back loop exists between CDO at the cell surface and
myogenic bHLH factors in the nucleus, and that CDO
may be an integral component of the myogenic regulatory
network. In this regard, expression of cdo in early myo-
genic precursors (newly formed somites, dermomyotome)
could conceivably play a role in the determination or sta-
bilization of the myogenic lineage, collaborating with or
amplifying signals initiated by Wnt family members and
Sonic hedgehog produced by axial tissues, or by less well-
defined signals derived from surface ectoderm (Munster-
berg et al., 1995; Stern et al., 1995; Cossu et al., 1996). This
proposal, though speculative, is consistent with a require-
ment of muscle precursors within early somites for cell–cell
contact in their response to such tissues; i.e., the commu-
nity effect (Gurdon, 1988; Cossu et al., 1995). Further-
more, the temporal pattern of cdo expression in somites
and dermomyotome closely resembles that of myf-5 (Ott
et al., 1991), the myogenic bHLH factor expressed earliest
during embryogenesis and for which a role in determina-
tion is strongly indicated (Megeney and Rudnicki, 1995).
Nevertheless, CDO expression alone is not sufficient to
convert 10T1/2 cells to a myogenic phenotype. Although
establishing myogenic identity in vivo undoubtedly re-
quires a complex combination of positive and negative sig-The Journal of Cell Biology, Volume 143, 1998 412
nals provided by soluble and surface-bound signaling mol-
ecules (Tajbakhsh and Cossu, 1997), this negative result
with 10T1/2 cells should be interpreted with some caution
since CDO is apparently unable to bind to itself, and ro-
dent embryo fibroblast cell lines display little binding ac-
tivity for soluble CDO fusion proteins (J.-S. Kang, P.J.
Mulieri, F. Cole, and R.S. Krauss, unpublished data).
Thus, CDO expressed at the surface of a 10T1/2 cell may
be unengaged, and consequently nonfunctional.
Regardless of CDO’s potential role in determining the
myogenic lineage, it clearly plays a role in differentiation
of committed myoblasts. Because the signal for differenti-
ation of these cells in culture is withdrawal of serum
growth factors, the role of signaling molecules as negative
regulators has received the most emphasis (Olson, 1992).
The positive and possibly requisite role of CDO in differ-
entiation suggests that positive signals emanate from the
cell surface as well. Cadherins and N-CAM have both
been implicated in myoblast differentiation and/or fusion,
but whether these molecules serve as actual signal trans-
ducers or as adhesion molecules during myogenesis is not
clear (Peck and Walsh, 1993; McDonald et al., 1995). In
principle, CDO could act as a heterophilic CAM, but a sig-
naling role seems more likely since CDO exerted its ef-
fects on C2C12 and C2C12/Ras cells without producing
significant alterations in cell aggregation (data not shown). 
CDO and the Inverse Relationship Between 
Transformation and Differentiation
Myogenic differentiation is inhibited by a variety of onco-
genes and growth factors via multiple mechanisms (Ko-
nieczny et al., 1989; Lassar et al., 1989; Olson, 1992; Kong
et al., 1995). Oncogenic Ras in particular can inhibit differ-
entiation by transcriptional downregulation of myogenic
bHLH factors, and by multiple modes of posttranslational
inhibition of their activity (Lassar et al., 1989; Kong et al.,
1995). It is important to note that Ras and specific growth
factors can inhibit differentiation without necessarily forc-
ing the cells to remain proliferative in DM, suggesting the
existence of activities that are specific for this aspect of on-
coprotein or growth factor action (Spizz et al., 1986; Olson
et al., 1987). We and others have demonstrated that vari-
ous responses to Ras can be dissociated from one another,
indicating that distinct combinations of pathways control
individual aspects of the transformed phenotype (Lloyd et
al., 1989; Krauss et al., 1992; Joneson et al., 1996). It is
striking that CDO and MyoD each reactivate differentia-
tion of C2C12/Ras cells without altering the transformed
morphology or anchorage-independent growth of these
cells. The indistinguishable and highly specific effects of
CDO and MyoD on C2C12/Ras cells strongly reinforces
the notion of a close mechanistic connection between
these proteins. Myogenic bHLH factors, MEF-2, CDO,
and other proteins may comprise a complex network of
factors that auto- and cross-regulate each others’ expres-
sion and activity during myogenesis. Furthermore, the
ability of Ras to block myogenic differentiation is specifi-
cally linked to its ability to disrupt this network. Activated
Raf and a Ras effector loop mutant specific for activation
of Raf (Ras12V,35S; White et al., 1995) each downregu-
late CDO in fibroblasts (Kang et al., 1997; J.-S. Kang and
R.S. Krauss, unpublished data), so it is likely that Raf is a
major effector of Ras in this aspect of its actions. Prelimi-
nary data also indicate that CDO is not nonspecific in its
ability to override a block to differentiation; TGFb1 inhib-
its differentiation of C2C12 cells without downregulating
CDO expression, and C2C12/CDO cells are not resistant
to the inhibitory effects of TGFb1 (J.-S. Kang and R.S.
Krauss, unpublished data). 
Functions of the 5 1 3 Subfamily of Ig/FNIII
Repeat Proteins
The 5 1 3 subfamily of Ig/FNIII repeat proteins includes
the Robo-like receptors (one in Caenorhabditis elegans,
and two each in Drosophila, rats, and humans) that have
been implicated as axon guidance receptors in nematodes
and fruit flies, and likely play a similar role in mammals
(Kidd et al., 1998; Zallen et al., 1998). This study is the first
to implicate a member of the 5 1 3 subfamily, CDO, in the
myogenic program, and establishes that members of this
subfamily have highly diverse functions. It is intriguing
that the sole 5 1 3 protein in C. elegans (SAX-3/Robo) is
prominently expressed in muscle, as assessed by a reporter
gene (Zallen et al., 1998). sax-3 may encode multiple func-
tions that have been distributed among several genes that
arose by duplication and divergance during the course of
evolution. It will be interesting to determine if there are
defects in myogenesis in sax-3 mutants.
It should also be noted that although CDO participates
in the myogenic regulatory program, cdo expression is not
restricted to the myogenic lineage. cdo is also expressed at
high levels in the developing nervous system and other tis-
sues during embryogenesis (Fig. 1 and unpublished data).
Similar to its role in myoblasts, recent experiments indi-
cate that ectopic CDO expression can induce differentia-
tion of a neuroblastoma cell line (F. Cole, J. Feinleib, and
R.S. Krauss, unpublished data). We hypothesize that
CDO may play a role in mediating cell–cell interactions
that coordinate appropriate differentiation of specific lin-
eages during embryogenesis.
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